| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclerion Therapeutics, Inc. | Director | Common Stock | 21.7K | $73.5K | $3.40 | Nov 30, 2023 | Direct |
| Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 5, 2024 | Direct | ||
| GENOCEA BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 15K | Jul 1, 2021 | Direct | ||
| Pulmatrix, Inc. | Director | Stock Option (Right to Buy) | 2.44K | Jan 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| CYCN | Cyclerion Therapeutics, Inc. | Nov 30, 2023 | 0 | $0 | 3 | Dec 7, 2023 | Director |
| VYGR | Voyager Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
| PULM | Pulmatrix, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | Director |
| VYGR | Voyager Therapeutics, Inc. | Jul 14, 2022 | 1 | -$93.1K | 4 | Jul 18, 2022 | Director |
| VYGR | Voyager Therapeutics, Inc. | Jun 6, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| PULM | Pulmatrix, Inc. | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Director |
| VYGR | Voyager Therapeutics, Inc. | Jan 13, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Interim President & CEO, Director |
| GNCA | GENOCEA BIOSCIENCES, INC. | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
| VYGR | Voyager Therapeutics, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Interim President & CEO, Director |